Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 221 across all filing types
Latest filing 2022-12-14 M&A Activity
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that NeonMind Biosciences Inc. has signed a binding letter agreement to complete a reverse merger with Lancaster Lithium Inc. It details the terms of the transaction, including share consolidation, financing plans, related party considerations, regulatory approvals, and expected timelines. The content focuses on a merger transaction announcement rather than a full merger filing or proxy statement. There is no detailed financial data, management discussion, or regulatory form attached. The document is not a full Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or voting results announcement. The primary subject is the announcement of a merger transaction, which fits the category of M&A Activity (TAR). The document length and detail support this classification with high confidence.
2022-12-14 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing a management change at NeonMind Biosciences Inc., specifically the appointment of a new CEO and President and the resignation of the previous CEO. It contains no financial data, no detailed report, no voting results, no regulatory certifications, or other report types. The content is focused solely on management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Confidence is high given the clear and explicit content.
2022-12-09 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended August 31, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references an interim report but does not include the report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is 3035 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-11-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of NeonMind Biosciences Inc. regarding the interim financial report and interim MD&A for the period ended May 31, 2022. It is a Form 52-109FV2 Venture Issuer Basic Certificate, which is a certification of interim filings. The text explicitly states it is a certification and does not contain the actual interim financial data or analysis but rather attests to the accuracy and fair presentation of the interim filings. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than the interim report itself. The document length is short (2947 characters), and it is a certification, not the report itself.
2022-08-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended May 31, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3048 characters), consistent with a certification letter rather than a full report.
2022-08-02 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.